NSECertificate under SEBI (Depositories and Participants) Regulations, 20186 Jul 2026 · 6 Jul 2026, 11:55 am
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Sun Pharma Advanced Research Company Limited · SPARC
✦ AI Summary
Sun Pharma Advanced Research Company Limited has received a confirmation certificate under SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2026, indicating that securities received for dematerialization were confirmed and listed on stock exchanges.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Sun Pharma Advanced Research Company Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Attachments (1)
📄pdf
Download →
SPARC_06072026115519_Intimation06072026.pdf
View document text
SPARC/Sec/SE/2026-27/16 July 06, 2026
National Stock Exchange of India Ltd., BSE Limited,
Exchange Plaza, 5th Floor, Market Operations Dept.
Plot No. C/1, G Block, P. J. Towers,
Bandra Kurla Complex, Dalal Street,
Bandra (East), Mumbai – 400 051. Mumbai - 400 001.
National Securities Depository Ltd., Central Depository Services (India) Ltd.,
Trade World, Marathon Futurex, 25th floor,
Kamla Mills Compound, A-Wing, Mafatlal Mills Compound,
Lower Parel, N.M. Joshi Marg, Lower Parel,
Mumbai - 400 012 Mumbai 400 013
Scrip Symbol: SPARC Scrip Code: 532872
Dear Sir/ Madam,
Sub: Confirmation Certificate under Regulation 74(5) of SEBI (Depositories and
Participants) Regulations, 2018 [“the SEBI (DP) Regulations”] for the quarter ended
June 30, 2026.
Pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and
Participants) Regulations, 2018, please find enclosed the Confirmation Certificate dated July
01, 2026, received from the Company’s Registrar and Share Transfer Agent, MUFG Intime
(India) Private Limited, for the quarter ended June 30, 2026.
This is for your information and record.
Thanking you,
Yours faithfully,
For Sun Pharma Advanced Research Company Ltd.
Kajal Damania
Company Secretary and Compliance Officer
Encl: As above
MUFG Intime India Private Limited
(Formerly Link Intime India Private Limited)
CIN: U67190MH1999PTC118368
Registered Address:
C-101, Embassy 247, L.B.S. Marg,
Vikhroli (West), Mumbai - 400083.
Tel: +91 22 4918 6000
www.in.mpms.mufg.com
Date : 01-07-2026
The Compliance Officer/ Company Secretary
SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED
SPARC
AKOTA ROAD
AKOTA
VADODARA 390020
VADODARA
PINCODE : 390019
Sub : Confirmation Certificate under Regulation 74(5) of Securities and Exchange Board of India (Depositories and
Participants) Regulations, 2018.
Dear Sir/Madam,
In reference to the above captioned regulation, we hereby confirm that the securities received from the depository participants for
dematerialisation during the quarter ended 30th June 2026, were confirmed (accepted/rejected) to the depositories by us and that
securities comprised in the said certificates have been listed on the stock exchanges where the earlier issued securities are listed.
We hereby also confirm that the security certificates received for dematerialisation have been confirmed/rejected and the security
certificates received were mutilated and cancelled after due verification by the depository participant and the name of the
depositories have been substituted in the register of members as the registered owner within the prescribed timelines. We request
you to kindly take note of the above in your records.
Thanking you,
Yours faithfully,
For MUFG Intime India Private Limited
(Formerly Link Intime India Private Limited)
Ashok Shetty
Sr. Vice President-Corporate Registry
MUFG Intime India Private Limited
A part of MUFG Corporate Markets, a division of MUFG Pension & Market Services